EcoDrugPlus

Ensembl ID : ML435832a
Gene Symbol: -
External references: -
263 Possible Orthologues:

Ensembl ID : ML43585a
Gene Symbol: -
External references: -
128 Possible Orthologues:

Ensembl ID : ML43587a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML43661a
Gene Symbol: -
External references: -
132 Possible Orthologues:

Ensembl ID : ML43662a
Gene Symbol: -
External references: -
210 Possible Orthologues:

Ensembl ID : ML45008a
Gene Symbol: -
External references: -
130 Possible Orthologues:

Ensembl ID : ML45311a
Gene Symbol: -
External references: -
147 Possible Orthologues:

Ensembl ID : ML45527a
Gene Symbol: -
External references: -
680 Possible Orthologues:

Ensembl ID : ML45528a
Gene Symbol: -
External references: -
680 Possible Orthologues:

Ensembl ID : ML455312a
Gene Symbol: -
External references: -
409 Possible Orthologues:

Ensembl ID : ML455314a
Gene Symbol: -
External references: -
409 Possible Orthologues:

Ensembl ID : ML45833a
Gene Symbol: -
External references: -
111 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).